Blood-based mitochondrial respiratory chain function in major depression.

Area of Science:

• Neuroscience
• Biochemistry
• Genetics

Background:

• Mitochondrial dysfunction is linked to major depressive disorder (MDD).
• The Mitochondrial Health Index (MHI) previously correlated with stress and emotional states.

Purpose of the Study:

• To investigate mitochondrial respiratory chain (RC) activities, mitochondrial DNA copy number (mtDNAcn), and MHI in unmedicated MDD subjects versus healthy controls (HC).
• To explore if these mitochondrial markers predict response to SSRI treatment in MDD patients.

Main Methods:

• Assayed mitochondrial RC complexes I, II, IV, citrate synthase (CS), mtDNAcn, and MHI in peripheral blood mononuclear cells from 47 MDD subjects and 11 HC.
• Assessed SSRI treatment response (n=33) using >50% decrease on the Hamilton Depression Rating Scale (HRDS-25) after 8 weeks.

Main Results:

• No significant differences in MHI or other mitochondrial markers were found between MDD subjects and HCs.
• SSRI responders showed significantly higher baseline CS, mtDNAcn, and complex I activity compared to nonresponders.
• Complex I activity changes correlated with treatment response, decreasing in responders and increasing in nonresponders.

Conclusions:

• Mitochondrial markers did not differentiate MDD patients from controls but could distinguish SSRI responders from nonresponders.
• These findings suggest mitochondrial markers may serve as biomarkers for predicting SSRI treatment efficacy and identifying novel therapeutic targets for MDD.